6 Re-purposing of already approved drugs with a case study An interesting trend in OA drug development is the re-purposing of existing approved drugs or ones in advanced stages of clinical development.
← all excerpts
The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development.
1
—
—